Brought to you by 
Mtm laboratories raises €9mm with second round
19 Oct 2005
Executive Summary
Cancer diagnostics company mtm laboratories AG has grossed €9mm ($10.5mm) with the first closing of its Series B round to new lead investor HBM BioVentures and returning investors Heidelberg Innovation and Mannheim Holdings. The company plans to raise another €3mm ($3.5mm) before the end of September.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Mtm laboratories raises €9mm with second round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice